Why ZeroStack Corp.’s (ZSTK) Stock Is Down 15.79%
As of Friday, August 21, ZeroStack Corp.’s ZSTK share price has dipped by 15.79%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Commentary & Analysis
Why ZeroStack Corp.’s (ZSTK) Stock Is Down 6.96%
As of Friday, August 21, ZeroStack Corp.’s ZSTK share price has dipped by 6.96%, which has investors questioning if this is right time to buy.Jenna Brashear
Why ZeroStack Corp.’s (ZSTK) Stock Is Down 13.07%
As of Friday, August 21, ZeroStack Corp.’s ZSTK share price has dipped by 13.07%, which has investors questioning if this is right time to buy.Jenna Brashear
Why ZeroStack Corp.’s (ZSTK) Stock Is Down 12.65%
As of Friday, August 21, ZeroStack Corp.’s ZSTK share price has dipped by 12.65%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | ZSTK | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $82.4 | $1,968.0 | 19% |
|
| Shares Out (Mil) | 10.0 | 77.7 | 20% |
|
| Institutional Ownership | 8.8% | 86.6% | 6% |
|
| Float (Mil) | 6.9 | 52.1 | 15% |
|
| Beta | 1.71 | 0.75 | 88% |
|
| Avg Daily Volume (000s) | 2,642 | 612 | 86% |
|
| Price Change (52-week) |
(76.7%) | 79.8% | 7% |
|
| Growth | ZSTK | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 224.0% | 10.9% | 100% |
|
| Net Income (5yr) | (53.2%) | (1.6%) | 6% |
|
| EPS (5yr) | 34.8% | 0.3% | 85 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (79.7%) | (17.9%) | 1% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ZSTK | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $40 | $1,504 | 18% |
|
| Net Income (TTM) (Mil) | ($178) | $28 | 7% |
|
| EPS (TTM) | ($23.812) | $0.200 | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | $162 | 24% |
|
| Net Cash Flow (TTM) (Mil) | na | $9 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $338 | 13% |
|
| Enterprise Value (Q1) (Mil) | $29 | $2,416 | 14% |
|
| Valuation | ZSTK | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.83 | 2.82 | 16% |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | ZSTK | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 13.1% | 27.8% | 12% |
|
| Net Margin | (444.2%) | 1.2% | 2% |
|
| ROA | (743.2%) | 2.2% | 0% |
|
| ROE | na | 7.2% | na |
|
| Liabilities to Assets | 45.1% | 58.6% | 36% |
|
| F-Score | 4 | 5 | 33% |
|
ZeroStack Corp. did not pass any screens on 8/21/2026.
